EUVIMEDEUVIMED entdecken
Crossref

Systematic Identification and Analysis of Angiotensin II Type I Receptor Targeting Material Basis in Tibetan Medicine Formula Bawei Chenxiang Powder

Xinyi Yuan, Liangxi Li, Ting Long, Jiangmin Liao, Zuyun Dong, Zimu Zhou, Huating Huang, Yimeng Zhao, Xu Ji

Journal of Separation Science · 2026-10 · 49 (10)

DOI: 10.1002/jssc.70562 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Separation Science, online erschienen am 29.10.2026. Verfasst von Xinyi Yuan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Tibetan Medicine Detection Technology, Ministry of Education, Xizang Minzu University, Xianyang, P. R. China. Hauptthemen laut MEDLINE: Receptor, Angiotensin, Type 1, Drugs, Chinese Herbal, Angiotensin II Type 1 Receptor Blockers. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Tibet Autonomous Region, Scientific Research Project of Xizang Minzu University, Young Scholar Cultivation Program, funded by Xizang Minzu University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pharmacodynamic material basis and mechanism of action of Bawei Chenxiang Powder (BWCP), a commonly prescribed Tibetan medicinal formulation for cardiovascular diseases, remain largely unclear. To address this issue, we established an angiotensin II type 1 receptor (AT 1 R) chromatographic method coupled with mass spectrometry for the systematic screening and identification of AT 1 R‐targeting bioactive compounds from BWCP for the first time. Five active components—myristicin, dehydrocostus lactone, naringenin, pinocembrin, and costunolide—were successfully identified as AT 1 R ligands from BWCP. Frontal analysis was employed to determine the binding constants of these compounds to AT 1 R, yielding values of (1.09 ± 0.15) × 10 4 M − 1 for myristicin, (1.59 ± 0.02) × 10 4 M − 1 for dehydrocostus lactone, (2.24 ± 0.50) × 10 4 M − 1 for naringenin, (6.09 ± 0.05) × 10 4 M − 1 for pinocembrin, and (2.59 ± 0.35) × 10 4 M − 1 for costunolide. Competitive displacement assays revealed that all five compounds share the same binding site with the clinically used AT 1 R antagonist valsartan, a finding further corroborated by molecular docking, which confirmed the affinity ranking and the overlapping binding pocket with valsartan. Collectively, this study demonstrates that AT 1 R receptor chromatography, based on specific molecular recognition, enables efficient screening and separation of target ligands from complex natural product matrices, thereby providing a novel and powerful technological platform for bioactive constituent research in ethnomedicines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Angiotensin, Type 1Drugs, Chinese HerbalAngiotensin II Type 1 Receptor BlockersFlavanonesPowdersMedicine, Tibetan TraditionalLactonesSesquiterpenesMolecular Docking SimulationChromatography, High Pressure LiquidAllylbenzene DerivativesHumansMass SpectrometryMolecular StructureLigands

Stichwörter der Autor:innen

Bawei Chenxiang PowderTibetan medicineangiotensin II type 1 receptormaterial basisreceptor chromatography

Substanzen

Receptor, Angiotensin, Type 1FlavanonesnaringeninPowdersLactonespinocembrinSesquiterpenesdehydrocostus lactonecostunolideDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Engineering Research Center of Tibetan Medicine Detection Technology, Ministry of Education, Xizang Minzu University, Xianyang, P. R. China.
  • Joint Laboratory for Research on Active Components and Pharmacological Mechanism of Tibetan Materia Medica, Tibetan Medical Research Center of Tibet, Xizang Minzu University, Xianyang, P. R. China.
  • Qilu Institute of Technology, Jinan, P. R. China.

Förderung

  • Natural Science Foundation of Tibet Autonomous Region
  • Scientific Research Project of Xizang Minzu University
  • Young Scholar Cultivation Program, funded by Xizang Minzu University
  • Innovation and Entrepreneurship Training Program of Xizang Minzu University

Zitieren

APA

Yuan, X., Li, L., Long, T., Liao, J., Dong, Z., Zhou, Z., Huang, H., Zhao, Y., & Ji, X. (2026). Systematic Identification and Analysis of Angiotensin II Type I Receptor Targeting Material Basis in Tibetan Medicine Formula Bawei Chenxiang Powder. Journal of Separation Science, 49(10). https://doi.org/10.1002/jssc.70562

Vancouver

Yuan X, Li L, Long T, Liao J, Dong Z, Zhou Z, et al. Systematic Identification and Analysis of Angiotensin II Type I Receptor Targeting Material Basis in Tibetan Medicine Formula Bawei Chenxiang Powder. Journal of Separation Science. 2026;49(10). doi:10.1002/jssc.70562

BibTeX
@article{Yuan2026,
  author = {Yuan, Xinyi and Li, Liangxi and Long, Ting and Liao, Jiangmin and Dong, Zuyun and Zhou, Zimu and Huang, Huating and Zhao, Yimeng and Ji, Xu},
  title = {Systematic Identification and Analysis of Angiotensin II Type I Receptor Targeting Material Basis in Tibetan Medicine Formula Bawei Chenxiang Powder},
  journal = {Journal of Separation Science},
  year = {2026},
  volume = {49},
  number = {10},
  doi = {10.1002/jssc.70562}
}
Kostenlos starten →